Clinical trial NCT06859528: Step Up to PD: A Community-based Walking Program for People With Parkinson's Disease
Official title: Step Up to PD: A Community-based Walking Program for People With Parkinson's Disease
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Parkinson Disease
Parkinson Disease, Idiopathic
Keywords: Walking
Physical Activity
Social Connectedness
Loneliness
Lead sponsor: St. Louis University
Sponsor class: OTHER
First posted: 2025-03-05
Enrollment: 40
Sex: ALL
Minimum age (years): 30
Maximum age (years): 85
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: TREATMENT

Brief summary: This study will investigate the feasibility of a 6-month community walking program for people with Parkinson's disease (PD) and their care partners in greater Saint Louis, Missouri region. The walking program will consist of weekly, organized walking groups at the Missouri Botanical Gardens. Participants in the program will use Nordic walking poles during the walks. The walking group(s) will meet once per week and will be supervised by walking group leaders from Saint Louis University. Participants will be given a smart watch to wear that will help step counts will be tracked in real-time. The program is designed to get people with Parkinson's disease out of their homes, cultivate a culture of connection with others with Parkinson's disease, and to be collectively accountable for a common goal toward increasing their physical and social engagement in their communities.


Eligibility criteria: Inclusion Criteria:

* 30-85 years old
* Neurologist-diagnosed Parkinson's disease
* Able to walk independently with or without a walking aid (e.g., cane, walker)
* Willing to participate in study for at least 6 months

Exclusion Criteria:

* Health diagnosis that would limit exercise participation (e.g., heart problems, uncontrolled blood pressure, exercise-induced asthma).
* Additional neurologic disease or injury beyond Parkinson's disease.
* Evidence of significant cognitive impairment. This will be determined by completing the Montreal Cognitive Assessment
* Participants with poor walking ability (determined using the Timed Up and Go Test during initial testing).

Primary outcomes:
measure: Safety/Rate of Falls - Feasibility
timeFrame: From enrollment to both the 6 and 12 month endpoints
measure: Enrollment - Feasibility
timeFrame: Through enrollment of all the study participants
measure: Attendance - Feasibility
timeFrame: Enrollment through the 6- and 12-month endpoints
Secondary outcomes:
measure: Steps per Day
timeFrame: From baseline assessment through the the end of the fall reporting period at 18 months
measure: Balance Discordance
timeFrame: From baseline assessment through the 6- and 12-month endpoints
measure: Loneliness
timeFrame: From baseline assessment through the 6- and 12-month endpoints
measure: Social Connection
timeFrame: From baseline assessment through the 6- and 12-month endpoints
Other outcomes:
Locations:
city: St. Louis
country: United States
facility: Integrated Health and Movement Science Laboratory, Saint Louis University
state: Missouri
Study officials:
References: